Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CD3 zeta chain (CD247) is a crucial transmembrane subunit of the T-cell receptor (TCR)-CD3 complex. It plays a critical role in adaptive immune responses by transmitting signals from antigen recognition to intracellular signaling pathways via its immunoreceptor tyrosine-based activation motifs (ITAMs). The ζζ homodimer provides six ITAMs to the complex, making it central to downstream signaling. Low expression or absence impairs immune responses. It interacts with JAK3, protein unc119 homolog, and other proteins involved in immunological synapse formation. Microbial proteins such as HIV Nef can modulate these interactions, affecting immune function. It is expressed predominantly in lymphoid tissues and peripheral blood mononuclear cells.
Not applicable (subunit of a receptor complex; direct targeting is rare)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD3 zeta chain.